DHI
36
3
CMCSA
49
3
DOV
48
2
ITW
45
2
LH
33
3
WMB
58
3
FAST
41
7
LOW
42
14
AZO
46
3
PEG
53
7
CAH
44
7
PFG
27
7
EOG
28
2
CLX
65
2
DVA
62
5
BXP
39
5
CAG
34
3
HUM
25
4
EIX
61
8
DD
44
2
DHI
36
3
CMCSA
49
3
DOV
48
2
ITW
45
2
LH
33
3
WMB
58
3
FAST
41
7
LOW
42
14
AZO
46
3
PEG
53
7
CAH
44
7
PFG
27
7
EOG
28
2
CLX
65
2
DVA
62
5
BXP
39
5
CAG
34
3
HUM
25
4
EIX
61
8
DD
44
2
Financhill
Back

LakeShore Biopharma 10K Form

Sell
50

LSB
LakeShore Biopharma

Last Price:
$2.84
Seasonality Move:
16.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LSB News And Ratings

See the #1 stock for the next 7 days that we like better than LSB

LSB Financial Statistics

Sales & Book Value

Annual Sales: $80.2M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $4.50
Price / Book: 0.66

Profitability

EPS (TTM): -2.00650
Net Income (TTM): $-6.7M
Gross Margin: $63.7M
Return on Equity: -7.94%
Return on Assets: -3.11%

LakeShore Biopharma Earnings Forecast

Key LakeShore Biopharma Financial Ratios

  • The Gross Profit Margin over the past 4 years for LSB is 79.48%.
  • The Selling, General & Administrative Expenses for LSB have been equal to 74.66% of Gross Profit Margin.
  • The Research & Development expenses have been 52.81% of Revenue.
  • The Interest Expense is -10.23% of Operating Income.
  • The Net Earning history of LSB is -75.59% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

LakeShore Biopharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: LSB
Website: lakeshorebio.com

Debt

Debt-to-Equity Ratio: 0.61
Current Ratio: 1.17
Quick Ratio: 0.79

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

LSB Technical Analysis vs Fundamental Analysis

Sell
50
LakeShore Biopharma (LSB) is a Sell

Is LakeShore Biopharma a Buy or a Sell?